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Summary.-The delay in regrowth to 10 mm diameter of a transplanted carcinoma
in mice was used to estimate the effect ofthe hypoxic-cell radiosensitizer Ro-07-0582.
When 1 mg/g body wt. was given before a single dose of X-rays, adose-enhancement
ratio of 2-0 was found. When the drug was given immediately after irradiation,
a large cytotoxic effect was observed, equivalent to an enhancement ratio of 1-3.
These results were confirmed by determining the X-ray doses required for the local
control of50% of the tumours at 80 days after irradiation.
The capacity of the tumour for repair of sublethal X-ray injury within 24 h was
similar to that for several normal tissues.
THE radiobiological properties of a
squamous cell carcinoma which had pre-
viously been investigated by the excision
and cell dilution method (Hewitt, Chan
and Blake, 1967) were here studied,
using the in situ methods of tumour
regrowth and local control.
A major reason for this study was
the exceptional finding of no radiosensi-
tization in this tumour by the electron-
affinic compound Ro-07-0582 using the
dilution method (Hewitt, private com-
munication). All other tumours so far
studied have shown X-ray dose-enhance-
ment ratios of about 2 0, using 1 mg/g
body wt. of the drug. The question
asked was whether this lack of radio-
sensitization was due to a difference in
tumour type, or could be explained by
the different methods of assessing tumour
response.
In addition, information was sought
about the shrinkage after irradiation, the
proportion of hypoxic cells, and the
amount ofintracellular repair of sublethal
injury that could occur in 24 h in this
tumour.
MATERIALS AND METHODS
The tumour, Squamous Carcinoma D,
was obtained from Dr H. B. Hewitt. It
arose spontaneously in his colony ofWHT/Ht
mice at the Gray Laboratory in 1965 as a
keratinizing squamous carcinoma, but has
since lost the ability to produce keratin and
is now anaplastic. The origin ofthe tumour
and its use in radiobiological cell survival
studies has previously been described (Hewitt
et al., 1967).
For the present experiments, the tumours
were implanted s.c. by trocar, on the ventral
wall of the thorax of 8-12-week-old male
WHT/Ht mice, under Penthrane anaesthesia.
The tumours grew readily, forming fairly
round, freely movable tumours, which
were selected for irradiation when they
reached a mean diameter of between 5'0
and 6-5 mm, at which time they had a
volume-doubling time of 2 days.
The mice were anaesthetized with 60
mg/kg Na pentobarbitone and irradiated
breathing air at room temperature. The
X-irradiations were performed at 240 kV
and 15 mA, using i mm Cu and 1 mm Al
filter to give a half-value layer of 1-3 mm Cu.
The dose rate was 2-4/Gy min. The
irradiations were performed as described byS. A. HILL AND J. F. FOWLER
Fowler et al. (1975), except that the mice
were breathing air at room temperature
(about 25°C) instead of warmed 02. Four
mice were irradiated simultaneously and
turned through 180° halfway through each
irradiation. To aid resuscitation, each mouse
was given 0 5 mg bemigride i.p. after ir-
radiation.
The following treatments were employed:
(a) Single doses of X-rays.
(b) Single doses of X-rays plus 1 mg/g
body wt. of the radiosensitizing drug Ro-07-
0582, dissolved in isotonic saline, injected
i.p. 30 min before irradiation.
(c) Single doses of X-rays plus 1 mg/g
Ro-07-0582 i.p. immediately after irradiation.
(d) Single doses of X-rays to the tumours
made hypoxic by clamping off the blood
supply to the tumour for 10 min before and
during irradiation.
(e) Single doses of X-rays followed imme-
diately by hypoxia, the blood supply to
the tumour being occluded by a clamp for
the time irradiation lasted plus 10 min.
(f) 1 mg/g Ro-07-0582 i.p., 30 min before
irradiation, plus application of clamp 10 min
before and during single doses of X-rays.
(g) 2 equal fractions of X-rays, 24 h
apart, to tumours clamped 10 min before
each irradiation.
After treatment, the tumours were meas-
ured 3 times per week over 3 perpendicular
diameters, using vernier calipers, until they
reached a mean diameter of at least 12 mm,
at which time the animals were killed. If
the size of a tumour at irradiation was not
exactly 5 5 mm mean diameter, its growth
curve was moved vertically so as to stan-
dardize it to 5-5 mm at irradiation (Dene-
kamp and Harris, 1975). The number of
days taken to reach 10 mm mean diameter
(equivalent to 2-5 volume doublings) was
then measured for each individual tumour,
enabling a mean delay and standard error
to be calculated for each dose group. This
delay could then be plotted as " effect " vs
X-ray dose.
Due to the high incidence of metastases,
primarily to the lungs, long-term tumour-
control experiments with this tumour were
difficult, but 3 such experiments have been
performed and the X-ray dose required
for local control of 5000 of the tumours
(the TCD50) was determined for single
doses of X-rays alone, or with 1 mg/g
Ro-07-0582 given 30 min before irradiation,
or 1 mg/g Ro-07-0582 immediately after
irradiation. Mice bearing this tumour also
commonly displayed eachexia, becoming sick
and losing weight rapidly as the tumour
increased in size. To try to overcome this,
the tumour was implanted into F1 hybrid
mice (WHT Y x CBA c'). However, the
delay in regrowth response of the tumour
to X-rays was found to be different in these
mice and their use was discontinued.
RESULTS
A series of growth curves for tumours
given a single dose of X-rays is shown
in Fig. 1. The vertical bars represent
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FIG. 1. Growth curves for control and irradiated tumours (Squamous Carcinoma D) after single
doses of X-rays. The vertical error bars are standard errors of the mean for each grouip of tumours
on a particular day, and the numbers in brackets denote the number of tumours in each dose
group.
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the standard error of the mean diameter
for each group of tumours on a particular
day. A control curve is shown for
animals which received no radiation. At
all doses below 25 Gy, the tumours
continued to grow for 1 or 2 days after
irradiation, followed by shrinkage and
eventual regrowth at different times.
Fig. 2 shows two dose-response curves
constructed by estimating the time taken
for each individual tumour to grow
from 5 5 to 10 mm mean diameter and
plotting the mean for the group of
animals. It can be seen that the tumours
in F1 mice grew slightly faster. They
also appeared to be less sensitive to
X-rays than when implanted in the WHT
mice (Fig. 2). However, if the delay
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induced by X-rays was divided by the
normal doubling time, there would be
no difference. All further experiments
were performed using the WHT/Ht
mice.
Two curves are shown in Fig. 3 for
tumours irradiated in air or under hypoxic
conditions, i.e., 10 min after occluding
the blood supply with a metal clamp.
Also shown are two single points for
animals whose tumours were made hyp-
oxic immediately after irradiation, clamp-
ing being maintained for the same periods.
The curve for control animals irradiated
in air appears to be biphasic, with a
break point at about 10 Gy, from which
point it approaches the smooth and less
steep hypoxic curve. The two " clamped
-o 10 20
DOSE (GRAY)
30
Fia. 2. Dose-response curves plotted as the
time taken to regrow to 10 mm mean dia-
meter as a function of irradiation dose in
gray. The two curves show the difference
in response to single doses of X-rays, when
the tumour is implanted into either
WHT/Ht or Fl hybrid mice.
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FIG. 3.-Dose-response curves for tumours
in air-breathing animals irradiated with
single doses of X-rays with or without
clamping for 10 min before and during
irradiation to make the tumours hypoxic.
Two points are also shown for tumours
which were clamped immediately after
irradiation for the time of the X-ray dose
plus 10 min; these fall on the " air " curve.
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FIG. 4. (a) Dose-response curves for tumours in air-breathing animals irradiated with single doses
of X-rays with or without an i.p. injection of 1 mg/g Ro-07-0582 30 min before irradiation. The
enhancement ratios for different levels of damage are given on the right hand side. Three points
arealso shown for Ro-07-0582 given 20 min before clamping the tumours, whichwere thenirradiated
10 min later. (b) Dose-response curve for animals injected with 1 mg/g Ro-07-0582 immediatelyafter
irradiation, plotted against the " Air (control )" curve and the " Air 0582 Before " curve from
Fig. 4a (dotted).
after X-rays " points fall exactly on the
air curve, and it can therefore be said
that in this tumour clamping alone has no
effect.
Fig. 4 shows the data for animals
irradiated in air with or without the
drug Ro-07-0582 (1 mg/g). The control
curve for X-rays only is the same biphasic
curve as was plotted in Fig. 3. The
curve for animals injected with 1 mg/g
Ro-07-0582 30 min before irradiation is
smooth, and indicates that there is an
increasing sensitization with increasing
dose of X-rays. The enhancement ratios
range from 1*3, below the breakpoint
on the X-ray-only curve, to over 2-0 at
10 Gy on the Ro-07-0582 curve. When
Ro-07-0582 was given immediately after
the X-rays (Fig. 4b) the points fell on
a biphasic curve approximately parallel
to the control line. This displacement
from the air curve is interpreted as
reflecting direct cytotoxic action of the
drug, which is known to be specific for
hypoxic cells, as discussed below. This
cytotoxic action was equivalent to a
post-irradiation enhancement ratio of be-
tween 1P2 and 1P4 and is consistent with
killing about 50% of the hypoxic cells in
the tumour.
Three points are shown in Fig. 4a for
Ro-07-0582 given before clamping and
then irradiating the tumours. They were
not significantly different from the curve
drawn through the corresponding points
without clamping.
Corresponding data for the tumour
control experiments are plotted in Fig. 5.
Tumours of more than 4 mm mean
diameter at 80 days were classified as
local recurrences, those between 2 and
4 mm as ambiguous, and less than 2 mm
diameter as locally controlled. In prac-
tice, none of the mice which survived to
80 days had palpable tumours, and none
developed in the period between 80 and
150 days. However, by 80 days a sig-
nificant proportion of the mice were
lost due to metastases: almost30% ofmice
in the X-ray-only experiment and 45% of
mice receiving 1 mg/g Ro-07-0582. Only
those animals which survived to 80 days,
orwere killedbeforethis time with a recur-
rent tumour, were included in the analysis.
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FIG. 5.-The proportion of tumours locally controlled at 80 (lays after irradiation plotted against
X-ray dose. The three curves shown are (from right to left) for X-rays onlv, for X-rays immedi-
ately followed by i.p. injection of 1 mg/g Ro-07-0582 (ER 1-24 ± 0-12), and for i.p. injection
of 1 mg/g Ro-07-0582 30 min before a single dose of X-rays (ER 2-0 ± 0-2). The horizontal
bars represent standard errors of the mean at the TCD50 level.
The TCD50 and s.e. mean value were
calculated using the computer programme
devised by Dr E. H. Porter ofthe Glasgow
Institute of Radiotherapeutics and Dr
L. J. Peters of the Gray Laboratory, as
described by Fowler et al. (1974a).
In Fig. 5 it can be seen that the TCD50
was reduced from 46 to 23 Gy (i.e.
ER 2.0) when Ro-07-0582 was given
before irradiation; and to 37 Gy (ER-
1-24) when the drug was given immediately
afterwards.
Fig. 6 shows the regrowth of tumours
made hypoxic by clamping, to single
doses and to two equal fractions of
X-rays 24 h apart. The extra dose needed
(D2 -D1) to give a delay of 10 to 30
days when the irradiation was given in
two fractions (D2) rather than as a
single dose (D1) varied from 6 to 14 Gy.
This represents the repair occurring within
24 h.
In order to make comparison with
values obtained for well oxygenated nor-
mal tissues, all the hypoxic radiation
doses should be divided by an assumed
oxygen enhancement ratio (OER) which
may be 2-5 to 3 0, including the hypoxic
D2- D1 value. In previous experiments
on skin reactions, where reoxygenation
was not a problem, it was found that the
clamped-off D2 D1 was indeed 2-5 to
3 0 times larger than the measured oxic
D2 D1 (Fowler et al., 1965). In the
present case we do not wish to under-
estimate the magnitude of D2 D1, so
the lower OER of 2 5 is assumed. The
resulting ' oxic equivalent " values of
D2 D1 have been plotted against the
size of the first dose in Fig. 6b, together
with data for normal tissues and 3 other
tumours (see figure legend). It can be
seen that the amount of repair in this
tumour is similar to that in skin and
intestine, and appears to be higher than
in the other 3 tumours.
DISCUSSION
General properties of the tumour
This tumour does not shrink until
at least 3 days after doses of 15 or 20 Gy,
as shown in Fig. 1. Therefore it behaves
differently from the carcinomas studied
by Denekamp (1972) all except one of
which shrank within a day after such
doses. It does however shrink within
3 days after doses of 25 to 40 Gy.
Fig. 2 indicates that the transplanted
tumours grew slightly more rapidly in
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FIG. 6.- (a) Dose-reponse curves for clamped
tumours given single doses or two equal
fractions of X-rays separated by 24 h.
(b) The capacity for " oxic " repair of
sublethal injury in 24 h (i.e. D2 - D1) v8
the size of the first of the two doses. Both
axes record the measured hypoxic doses,
divided by an assumed OER of 2-5. The
dotted lines show results for some normal
tissues. * C3H mouse tumours (Fowler
et al., 1975), * Carcinoma NT (24 h) and
o Sarcoma B (24 h; Denekamp and Harris,
1976a). The full line shows another set
of results for Carcinoma NT at 48 h
(Denekamp and Harris, 1976b). The
tumour results were obtained by dividing
the clamped-off D2 - D1 by an assumed
OER of 2-5.
F1 hybrids than in the WHT mice (i.e.
at zero dose) and also that they were less
radiosensitive in the F1 mice.
Proportion of hypoxic cells
The proportion of hypoxic cells in
the tumour can be estimated from the
shape of the curve for aerobic tumours
and its position relative to the clamped
hypoxic curve (Fig. 3). The " in air "
curve is biphasic, with an initial sensitive
region up to 10 Gy, then becoming more
resistant and " breaking " towards the
clamped curve, as the hypoxic cells
become important. The fraction of hyp-
oxic cells can be estimated from the data
in three ways:
(1)From the position ofthebreakpoint
in the " in air " response curve which
occurs at 10 Gy or possibly slightly
lower. By assuming a D0 value of
35 Gy for hypoxic cells, an oxygen
enhancement ratio (OER) of between
2-5 and 3-0 and a DQ value of 4 to 6 Gy,
the proportion of hypoxic cells can be
computed to be between 10 and 30%.
This value is not inconsistent with the
estimate of 18% found by Hewitt et al.
(1967) using excised tumours and a
cell-dilution assay.
(2) From the displacement of the
clamped-off with respect to the " in air "
curve: they were not significantly different
at high doses. By assuming the same
survival-curve parameters, the hypoxic
proportion can be calculated to be in
the range 50 to 100%. However, this
convergence of the curves at high doses
may be due to a greater capacity for
recovery of potentially lethal damage
in chronically hypoxic cells than in
those made acutely hypoxic by clamping,
as suggested by McNally (private com-
munication). This would lead to a higher
estimate of the hypoxic fraction than
obtained by a method in which the
tumour was excised soon after irradiation.
(3) From converting the regrowth
delay curves to " pseudo-survival curves "
(Denekamp and Harris, 1975) by ex-
pressing the delay in terms of number of
cell doublings needed to restore the
tumour to its original size. This can
be done by taking the time to regrow
to 10 mm for the irradiated tumours,
subtracting the corresponding time for
the unirradiated (control) tumours and
dividing by the volume-doubling time,
e.g. 2 days. It was established that the
time to grow from 8 to 10 mm was not
significantly greater after doses of 5 to
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25 G(y (2.75 i 041), than in the unirradi-
ated control group (2.63 + 0 2). From
the curves so drawn, the resistant, pre-
sumably hypoxic, portion of the aerobic
curve can be extrapolated back to zero
dose and gives an estimate of 10%
hypoxic cells. Thus the proportion of
hypoxic cells lies between 10% and
10000, depending upon the method of
estimation used.
Radiosensitization with Ro-07-0582
Fig. 4a shows that, when 1 mg/g
of the electron-affinic radiosensitizer is
given before irradiation, a large dose-
reduction factor or " sensitizer enhance-
ment ratio " is obtained, between 2 0
and 2-4 over the dose range 18 to 25 Gy
on the X-rays-only curve in air. This
value is similar to other large values
reported for several types of experimental
tumour in mice using a variety of assay
systems (Sheldon, Foster and Fowler,
1974; Denekamp and Harris, 1975; Brown,
1975; Begg, 1977; Sheldon and Hill,
1977; McNally, 1975; Stone and Withers,
1975; Rauth, Kaufman and Thomson,
1975; Bleehen, 1976; Denekamp and
Stewart, personal communication). It
differs however from the value of 1 0
reported by Hewitt for a cell-dilution
experiment on this tumour, Squamous
Carcinoma D, where two i.v. injections
of 0o44 mg/g body wt. were given, 90
and 20 min before exposure to a dose
of 18 Gy (private communication). A
part of this difference can probably be
explained by the direct cytotoxic effect
of Ro-07-0582 on hypoxic cells.
The magnitude of this cytotoxic effect
is indicated by the distance apart of
the " Air (control) " curve and the " Air
with 0582 after " curve in Fig. 4b. The
enhancement ratio is not significantly
different from 1P3, both above and below
the breakpoint in the Air (control) curve.
At doses below 10 Gy this cytotoxic
effect could be the reason for the whole
of the enhancement, corresponding to
2 Gy or 2-3 days of delay at doses from
zero to about 8 Gy. At the dose of
18 Gy in air, as used by Dr Hewitt, the
total sensitization ratio in situ was 2-0, of
which 1 4 would of course not be seen
in his method of excising tumours imme-
diately after irradiation. The remaining
difference, a factor of 2-0/1-4 1-4, might
just be covered by the experimental
errors in both methods.
The total effect on the tumour is of
course what is measured in sitt: both
effects contribute usefully to the eradica-
tion of hypoxic cells. The cytotoxic
effect is large in the present tumours.
Post-radiation (i.e. cytotoxic) enhance-
ments of 1a17 (Brown, personal com-
munication), 1 1-1 4 (Denekamp and Har-
ris, 1975), and 1P0-1 2 (Begg, 1977),
have been reported, but in two other
types of mouse carcinoma no significant
post-irradiation enhancement was ob-
served (Sheldon et al., 1974; Sheldon and
Hill, 1977).
To test whether the drug was in fact
penetrating to all the naturally hypoxic
cells, the tumours were made anoxic by
clamping, after an injection of Ro-07-0582
but before irradiating. This should de-
monstrate the maximum sensitizing effect
of the drug, since all the cells have been
made totally hypoxic. The results at
the two X-ray doses tested (Fig. 4a) were
the same as if the tumours had not been
clamped, thereby indicating that the
drug is indeed reaching the hypoxic
cells.
Repair in 24 h
Fig. 6 shows the response curves for
single doses and equal doses given 24 h
apart for tumours clamped off to make
all the cells hypoxic. In those circum-
stances, the value of D2 D1 represents
repair ofthe cells which are made uniform-
ly hypoxic during irradiation, without the
artefact of re-oxygenation. The values
of D2 D1 from Fig. 6a increased from
about 13 Gy to 15 Gy as D2 was varied
from 30 to 40 Gy. If D2 D1 is divided
by an arbitrarily assumed oxygen en-
hancement ratio of 2-5, the resulting
" repair of oxic cells " estimated is
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5*2-6*0 Gy. The extent of this repair
will vary with the dose per fraction
(I D2) as shown in Fig. 6b. In the
same figure the oxic repair in 24 h
measured in skin (Fowler et al., 1974b)
and in the intestinal mucosa of the
jejunum in 3 h (Withers, 1969) and of
the colon in 24 h (Withers, 1974) is
shown plotted against the size of the
first of the 2 radiation doses used. The
repair measured in 3 other types of
tumour in our laboratory is also shown.
In contrast to the present tumour, they
were not anaplastic. All the tumour
results were obtained by dividing the
repair measured in clamped-off tumours
by the OER of 2*5.
It can be seen from Fig. 6b that,
although the other 3 tumour results are
lower than the normal tissue results,
this is not so for the present tumour.
Repair appears to be similar to that in
some of the normal tissues. If an OER
of 3 had been assumed instead of 2-5,
the estimated repair in the tumour would
be correspondingly lower, but the general
conclusion would not be altered. In
this tumour there is no evidence of less
repair in 24 h than in normal tissues,
as indeed Withers (1969) concluded.
Nevertheless, Phillips (1972) considered
that the recovery of sarcomas and mam-
mary carcinomas was significant but was
" less than that of the normal skin and
gut ". It seems clear that different
types of tumour demonstrate different
amounts of repair in 24 h, large amounts
perhaps being associated with appreciable
repair of potentially lethal injury.
CONCLUSIONS
1. This squamous carcinoma did not
shrink until more than 3 days after
15-20 Gy.
2. Three different estimates of the
proportion of hypoxic cells in the tumour
gave values ranging from 10% to 100%.
No conclusion can yet be made about
the differences, although the higher value
may be partly explained by more recovery
of PLD occurring in chronically hypoxic
cells than in acutely hypoxic (clamped)
tumours, particularly after the higher
doses of radiation used.
3. Large enhancement ratios of 2-0-2-4
were observed at X-ray doses above
9 Gy, when 1 mg/g of Ro-07-0582 was
injected before irradiation. The value
of 10 (no enhancement), found earlier
by an excision method, may be explained
at least partly by a large cytotoxic effect
of the drug on hypoxic cells left in situ.
4. A large effect of cytotoxicity on
hypoxic cells was observed by injecting
Ro-07-0582 immediately after irradiation,
corresponding to an enhancement ratio
of about 1-3. In some other types of
tumour this cytotoxicity cannot be de-
monstrated.
5. The results of tumour-control ex-
periments agreed with those of the re-
growth-delay experiments, for both true
sensitization and post-irradiation enhance-
ment due to hypoxic cell cytotoxicity.
6. The 24-h repair of sublethal X-ray
injury in tumour cells, irradiated with
the blood supply occluded to make them
uniformly hypoxic, was similar to that
for some normal tissues.
7. The shape of the dose-response
curves in Fig. 3 is consistent with appre-
ciable repair of potentially lethal damage
in hypoxic cells specifically. This repair
of potentially lethal damage may be the
cause of the large amount of repair
mentioned in the previous conclusion.
We should like to thank Dr H. B.
Hewitt for providing the tumour; Angela
Walder, Ann Marriott and Suzanne Bull
for the breeding and care of the mice;
Dr J. Denekamp for helpful discussions;
Sandra Fairman for help with implanting
the tumour; Roche Products Ltd., Wel-
wyn Garden City, for supplying the
Ro-07-0582; and the Cancer Research
Campaign for support.
REFERENCES
BEGG, A. C. (1977) The Use of 1251-iododeoxyuridine
to Measure Hypoxic Cell Radiosensitization by
Ro-07-0582 in a Solicl Murine Tumour. Rad.
Res. (in press).Ro-07-0582 EFFECTS ON MOUSE TUMOUR 469
BLEEHEN, N. M. (1976) A Radiotherapist's View
of Radiosensitizers. In Modifications of Radio-
sensitivity ofBiologicalSystems. Vienna: I.A.E.A.
p. 1.
BROWN, J. M. (1975) Selective Radiosensitization
of the Hypoxic Cells of Mouse Tumors with the
Nitroimidazoles Metronidazole and Ro-07-0582.
Rad. Res. 64, 633.
DENEKAMP, J. (1972) The Relationship between
the "Cell Loss Factor" and the Immediate
Response to Radiation in Animal Tumours.
Eur. J. Cancer, 8, 335.
DENEKAMP, J. & HARRIS, S. R. (1975) Tests of
Two Electron-affinic Radiosensitizers In vivo
Using Regrowth of an Experimental Carcinoma.
Rad. Res., 61, 191.
DENEKAMP, J. & HARRIS, S. R. (1976a). Studies
of the Processes Occurring between Two Fractions
in Experimental Mouse Tumours. Int. J. Rad.
Oncol. Biol. PhysiCs, 1, 421.
DENEKAMP, J. & HARRIS, S. R. (1976b) The Response
of a Transplantable Tumour to Fractionated
Irradiation. 1. X-rays and the Hypoxic Cell
Radiosensitizer Ro-07-0582. Rad. Res., 66, 66.
FOWLER, J. F., DENEKAMP, J., SHELDON, P. W.,
SMITH, A. M., BEGG, A. C., HARRIS, S. R. &
PAGE, A. L. (1974a) Optimum Fractionation in
X-ray Treatment of C3H Mouse Mammary
Tumours. Br. J. Radiol., 47, 781.
FOWLER, J. F., DENEKAMP, J., DELAPEYRE, C.,
HARRIS, S. R. & SHELDON, P. W. (1974b) Skin
Reaction in Mice after Multi-fraction X-irradia-
tion. Int. J. Radiat. Biol., 25, 213.
FAWLER, J. F., KRAGT, K., Ellis, R. E., LINDOP, P.
& BERRY, R. J. (1965) The Effect ofDivided Doses
of 15 MeV Electrons on the Skin Response ofMice.
Int. J. Radiat. Biol., 9, 241.
FOWLER, J. F., SHELDON, P. W., BEGG, A. C.,
HILL, S. A. & SMITH, A. M. (1975) Biological
Properties and Response to X-rays of First-
generation Transplants of Spontaneous Mammary
Carcinomas in C3H Mice. Int. J. Radiat. Biol.,
27, 463.
HEWITT, H. B., CHAN, D. & BLAKE, E. (1967)
Survival Curves for Clonogenic Cells of a Murine
Keratinizing Squamous Carcinoma Irradiated In
vivo or under Hypoxic Conditions. Int. J.
Radiat. Biol., 12, 535.
MCNALLY, N. J. (1975) The Effect of an Hypoxic
Cell Sensitizer on Tumour Growth Delay and
Cell Survival. Implications for Cell Survival In
situt and In vitro. Br. J. Cancer, 32, 610.
PHILLIPS, T. L. (1972) Split-dose Recovery in
Euoxic and Hypoxic Normal and TIumour Cells.
Radiology, 105, 127.
RAUTH, A. M., KAUFMAN, K. & THOMSON, J. E.
(1975) In vivo Testing of Hypoxic Cell Radio-
sensitizers. In Radiation Research: Biomedical,
Chemical and Physical Perspectives. Eds 0. F.
Nygaard, H. Adler and W. K. Sinclair. New
York: Academic Press. p. 761.
SHELDON, P. W. & HILL, S. A. (1977) The Effect
of Hypoxic-cell Radiosensitizing Drugs on Local
Control by X-rays of a Transplanted Anaplastic
Tumour in Mice. Br. J. Cancer, 35, in press.
SHELDON, P. W., FOSTER, J. L. & FOWLER, J. F.
(1974) Radiosensitization of C3H Mouse Mam-
mary Tumours by a 2-Nitroimidazole Drug. Br.
J. Cancer, 30, 560.
STONE, H. B. & WITHERS, H. R. (1975) Enhance-
ment of the Radioresponse of a Murine Tumour
by a Nitroimidazole. Br. J. Radiol., 48, 411.
WITHERS, H. R. (1969) Capacity for Repair in
Cells of Normal and Malignant Tissues. In Proc.
Carmel Conf. on Time and Dose Relationships
in Radiation Biology as Applied to Radiotherapy.
Brookhvn. natn. Lab., Rept. No. 50203, p. 59.
WITHERS, H. R. (1974) Iso-effect Curves for Various
Proliferative Tissues in Experimental Animals.
In Proc. Conf. on Time-Dose Relationships in
Clinical Therapy. Eds W. L. Caldwell and D. D.
Tolbart. Madison: Univ. of Wisconsin. p. 30.